NVRO Market Cap History
Below is a table of the NVRO market cap history going back to 11/15/2014:

Date NVRO Market Cap
11/15/2014634.53M
2/28/20151.04B
4/30/20151.12B
7/31/20151.42B
10/31/20151.14B
2/12/20161.36B
4/29/20161.90B
7/29/20162.36B
10/31/20162.64B
2/14/20172.72B
4/30/20172.76B
7/31/20172.53B
10/31/20172.59B
2/14/20182.31B
4/30/20182.68B
7/27/20181.68B
10/31/20181.47B
2/14/20191.49B
4/30/20191.88B
7/31/20192.06B
7/17/20191.63B
10/31/20192.67B
2/14/20204.44B
4/27/20204.06B
7/30/20204.55B
10/30/20205.14B
2/16/20216.18B
4/28/20216.08B
7/28/20215.40B
10/29/20213.97B
2/16/20222.49B
4/27/20222.30B

Also see: NVRO Shares Outstanding History
and NVRO YTD Return
NVRO Historical Market Cap:
+18.88% CAGR
NVRO Historical Market Cap: +18.88% CAGR

Mouse over chart for data details
11/15/2014 ...4/27/2022
Nevro is a medical device company that has developed and commercialized the Senza® spinal cord stimulation system, a neuromodulation platform for the treatment of chronic pain, with the Senza® Omnia™ platform as an addition to the Senza family of products. Co.'s HF10 therapy, delivered by its Senza system is designed to treat back pain and leg pain. The Senza system is approved to create electrical impulses and its HF10 therapy for pain relief without paresthesia. HF10 therapy delivers waveforms with a programming algorithm. Senza is consisted of leads, a trial stimulator, an implantable pulse generator, surgical tools, a clinician programmer, a patient remote control and a mobile charger. We show 32 historical shares outstanding datapoints in our NVRO shares outstanding history coverage, used to compute NVRO market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing NVRO market cap history over the course of time is important for investors interested in comparing NVRO's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of NVRO versus a peer is one thing; comparing NVRO market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like NVRO can fluctuate over the course of history. With this page we aim to empower investors researching NVRO by allowing them to research the NVRO market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree NVRO Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Nevro (NVRO) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

NVST Market Cap History
NVTA Market Cap History
NVTR Market Cap History
NVUS Market Cap History
NXTC Market Cap History
NXTM Market Cap History
NYMX Market Cap History
OBLN Market Cap History
OCGN Market Cap History
OCUL Market Cap History
More Healthcare companies »

 

NVRO Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2022, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.